David Townend
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
David Townend has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Andre Dekker
Department of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands
2 shared publications - Florian van Daalen
Health promotion, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands
2 shared publications - Andrew Swan
Leeds Metropolitan University
1 shared publication - Anke Bruninx
Department of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands
1 shared publication - Annie Sorbie
University of Edinburgh School of Law, Old College, Edinburgh, UK
1 shared publication - Arnoud W. J. van 'T Hof
Department of Cardiology, Maastricht University Medical Center, Maastricht, The Netherlands
1 shared publication
Latest Publications
- Open Access
- 20 June 2025
- Published by Springer Nature in Ethics and Information Technology
- Vol. 27 (3) , 1-14
A critique of current approaches to privacy in machine learning
Access to large datasets, the rise of the Internet of Things (IoT) and the ease of collecting personal data, have led to significant breakthroughs in machine learning. However, they have also raised new concerns about privacy data protection. Controversies like the Facebook-Cambridge Analytica scandal highlight unethical practices in today’s digital landscape. Historical privacy incidents have led to the development of technical and legal solutions to protect data subjects’ right to privacy. However, within machine learning, these problems have largely been approached from a mathematical point of view, ignoring the larger context in which privacy is relevant. This technical approach has benefited data-controllers and failed to protect individuals adequately. Moreover, it has aligned with Big Tech organizations’ interests and allowed them to further push the discussion in a direction that is favorable to their interests. This paper reflects on current privacy approaches in machine learning and explores how various big organizations guide the public discourse, and how this harms data subjects. It also critiques the current data protection regulations, as they allow superficial compliance without addressing deeper ethical issues. Finally, it argues that redefining privacy to focus on harm to data subjects rather than on data breaches would benefit data subjects as well as society at large.
- 20 June 2025
- Published by Springer Nature in Ethics and Information Technology
- Vol. 27 (3) , 1-14
Open AccessA critique of current approaches to privacy in machine learning
Access to large datasets, the rise of the Internet of Things (IoT) and the ease of collecting personal data, have led to significant breakthroughs in machine learning. However, they have also raised new concerns about privacy data protection. Controversies like the Facebook-Cambridge Analytica scandal highlight unethical practices in today’s digital landscape. Historical privacy incidents have led to the development of technical and legal solutions to protect data subjects’ right to privacy. However, within machine learning, these problems have largely been approached from a mathematical point of view, ignoring the larger context in which privacy is relevant. This technical approach has benefited data-controllers and failed to protect individuals adequately. Moreover, it has aligned with Big Tech organizations’ interests and allowed them to further push the discussion in a direction that is favorable to their interests. This paper reflects on current privacy approaches in machine learning and explores how various big organizations guide the public discourse, and how this harms data subjects. It also critiques the current data protection regulations, as they allow superficial compliance without addressing deeper ethical issues. Finally, it argues that redefining privacy to focus on harm to data subjects rather than on data breaches would benefit data subjects as well as society at large.
- 8 August 2024
- Published by Taylor & Francis
- p. 81-101
Big Data research
This chapter is grounded in the experience of trying to reconcile the EU General Data Protection Regulation (EU GDPR) (and the EU Data Protection Directive) with potentials for the use of personal data in health research using “Big Data”. The secondary processing of already-gathered data is fundamental to recent data science methodology developments in medical research. These emerging data science methodologies promise a new dimension in the understanding of health and disease by unlocking previously siloed data. However, the established regulatory regime depends upon privacy and data protection laws that present conceptual and practical difficulties for the new data science methodologies. This chapter discusses these privacy and data protection difficulties, and then argues that solutions to the difficulties can be found in the law of confidentiality and in the equitable concept of the fiduciary duty.
- 8 August 2024
- Published by Taylor & Francis
- p. 81-101
Big Data research
This chapter is grounded in the experience of trying to reconcile the EU General Data Protection Regulation (EU GDPR) (and the EU Data Protection Directive) with potentials for the use of personal data in health research using “Big Data”. The secondary processing of already-gathered data is fundamental to recent data science methodology developments in medical research. These emerging data science methodologies promise a new dimension in the understanding of health and disease by unlocking previously siloed data. However, the established regulatory regime depends upon privacy and data protection laws that present conceptual and practical difficulties for the new data science methodologies. This chapter discusses these privacy and data protection difficulties, and then argues that solutions to the difficulties can be found in the law of confidentiality and in the equitable concept of the fiduciary duty.
- Open Access
- 17 October 2022
- Published by JMIR Publications Inc. in JMIR Cardio
- Vol. 6 (2) , e37437
Digital Health Solutions to Reduce the Burden of Atherosclerotic Cardiovascular Disease Proposed by the CARRIER Consortium
Digital health is a promising tool to support people with an elevated risk for atherosclerotic cardiovascular disease (ASCVD) and patients with an established disease to improve cardiovascular outcomes. Many digital health initiatives have been developed and employed. However, barriers to their large-scale implementation have remained. This paper focuses on these barriers and presents solutions as proposed by the Dutch CARRIER (ie, Coronary ARtery disease: Risk estimations and Interventions for prevention and EaRly detection) consortium. We will focus in 4 sections on the following: (1) the development process of an eHealth solution that will include design thinking and cocreation with relevant stakeholders; (2) the modeling approach for two clinical prediction models (CPMs) to identify people at risk of developing ASCVD and to guide interventions; (3) description of a federated data infrastructure to train the CPMs and to provide the eHealth solution with relevant data; and (4) discussion of an ethical and legal framework for responsible data handling in health care. The Dutch CARRIER consortium consists of a collaboration between experts in the fields of eHealth development, ASCVD, public health, big data, as well as ethics and law. The consortium focuses on reducing the burden of ASCVD. We believe the future of health care is data driven and supported by digital health. Therefore, we hope that our research will not only facilitate CARRIER consortium but may also facilitate other future health care initiatives.
- 17 October 2022
- Published by JMIR Publications Inc. in JMIR Cardio
- Vol. 6 (2) , e37437
Open AccessDigital Health Solutions to Reduce the Burden of Atherosclerotic Cardiovascular Disease Proposed by the CARRIER Consortium
Digital health is a promising tool to support people with an elevated risk for atherosclerotic cardiovascular disease (ASCVD) and patients with an established disease to improve cardiovascular outcomes. Many digital health initiatives have been developed and employed. However, barriers to their large-scale implementation have remained. This paper focuses on these barriers and presents solutions as proposed by the Dutch CARRIER (ie, Coronary ARtery disease: Risk estimations and Interventions for prevention and EaRly detection) consortium. We will focus in 4 sections on the following: (1) the development process of an eHealth solution that will include design thinking and cocreation with relevant stakeholders; (2) the modeling approach for two clinical prediction models (CPMs) to identify people at risk of developing ASCVD and to guide interventions; (3) description of a federated data infrastructure to train the CPMs and to provide the eHealth solution with relevant data; and (4) discussion of an ethical and legal framework for responsible data handling in health care. The Dutch CARRIER consortium consists of a collaboration between experts in the fields of eHealth development, ASCVD, public health, big data, as well as ethics and law. The consortium focuses on reducing the burden of ASCVD. We believe the future of health care is data driven and supported by digital health. Therefore, we hope that our research will not only facilitate CARRIER consortium but may also facilitate other future health care initiatives.
- Open Access
- 1 December 2021
- Published by Elsevier in Resuscitation
- Vol. 169, 136-142
Ethics of ECPR research
- 1 December 2021
- Published by Elsevier in Resuscitation
- Vol. 169, 136-142
Open AccessEthics of ECPR research
- Open Access
- 4 February 2021
- Published by Oxford University Press (OUP) in Journal of Law and the Biosciences
- Vol. 8 (2) , lsaa068
Examining the power of the social imaginary through competing narratives of data ownership in health research
This article explores the social imaginary in the context of data ownership and the (non-)delivery of the data sharing revolution in biomedicine. We contribute to this special issue on imaginaries by developing a method and paradigm of ‘competing narratives’. Despite multiple initiatives to encourage health data sharing, and a strong ‘open access’ agenda, the data sharing revolution is not yet delivered. Ownership is persistently (though inconsistently) presented as a barrier to data sharing. However, existing literature does not reveal how far appeals to ownership are part of the problem. This paper reports original, interdisciplinary research asking: in health research, in what ways, if at all, do notions of ownership (broadly conceived) of health-related data impact on sharing practices? Doctrinal and empirical research methods are used to expose evidence of drivers behind appeals to ownership in health data sharing. The findings speak to how funders and data custodians can better tailor existing and potential data sharing initiatives to perspectives and behaviors. The concept of ‘my data’ is important: notions of reward, opportunity, control, and safeguarding establish legitimate, potentially competing ‘ownership’ interests in data. In particular, this research raises questions about the long-term effectiveness of an open access ideology that ignores these subtleties. In conclusion we find power in the social imaginary of ownership with respect to biomedical data; however, that power emerges and is enacted in unexpected ways by multiple actors within the ecosystem, often driven by competing narratives about what is at stake. Importantly, formal legal property-type appeals to ownership appear to have far less power in the narratives about data than the ethical and social concerns that underpin responsible biomedical research.
- 4 February 2021
- Published by Oxford University Press (OUP) in Journal of Law and the Biosciences
- Vol. 8 (2) , lsaa068
Open AccessExamining the power of the social imaginary through competing narratives of data ownership in health research
This article explores the social imaginary in the context of data ownership and the (non-)delivery of the data sharing revolution in biomedicine. We contribute to this special issue on imaginaries by developing a method and paradigm of ‘competing narratives’. Despite multiple initiatives to encourage health data sharing, and a strong ‘open access’ agenda, the data sharing revolution is not yet delivered. Ownership is persistently (though inconsistently) presented as a barrier to data sharing. However, existing literature does not reveal how far appeals to ownership are part of the problem. This paper reports original, interdisciplinary research asking: in health research, in what ways, if at all, do notions of ownership (broadly conceived) of health-related data impact on sharing practices? Doctrinal and empirical research methods are used to expose evidence of drivers behind appeals to ownership in health data sharing. The findings speak to how funders and data custodians can better tailor existing and potential data sharing initiatives to perspectives and behaviors. The concept of ‘my data’ is important: notions of reward, opportunity, control, and safeguarding establish legitimate, potentially competing ‘ownership’ interests in data. In particular, this research raises questions about the long-term effectiveness of an open access ideology that ignores these subtleties. In conclusion we find power in the social imaginary of ownership with respect to biomedical data; however, that power emerges and is enacted in unexpected ways by multiple actors within the ecosystem, often driven by competing narratives about what is at stake. Importantly, formal legal property-type appeals to ownership appear to have far less power in the narratives about data than the ethical and social concerns that underpin responsible biomedical research.
- Open Access
- 17 August 2018
- Published by Springer Nature in Human Genetics
- Vol. 137 (8) , 657-664
Conclusion: harmonisation in genomic and health data sharing for research: an impossible dream?
There are clear benefits from genomics and health data sharing in research and in therapy for individuals across societies. At the same time, citizens have different expectations and fears about that data sharing. International legislation in relation with research ethics and practice and, particularly, data protection create a particular environment that, as is seen in the articles in part two of this special issue, are crying out for harmonisation both at a procedural but at fundamental conceptual levels. The law of data sharing is pulling in different directions. This paper poses the question, ‘harmonisation, an impossible dream?’ and the answer is a qualified ‘no’. The paper reflects on what can be seen in the papers in part two of the special issue. It then identifies three major areas of conceptual uncertainty in the new EU General Data Protection Regulation (not because it has superiority over other jurisdictions, but because it is a recent revision of data protection law that leaves universal conceptual questions unclear). Thereafter, the potential for Artificial Intelligence to meet some of the shortcomings is discussed. The paper ends with a consideration of the conditions under which data sharing harmonisation might be achieved: an understanding of a human rights approach and citizen sensitivities in considering the ‘public interest’; social liberalism as a basis of solidarity; and the profession of ‘researcher’.
- 17 August 2018
- Published by Springer Nature in Human Genetics
- Vol. 137 (8) , 657-664
Open AccessConclusion: harmonisation in genomic and health data sharing for research: an impossible dream?
There are clear benefits from genomics and health data sharing in research and in therapy for individuals across societies. At the same time, citizens have different expectations and fears about that data sharing. International legislation in relation with research ethics and practice and, particularly, data protection create a particular environment that, as is seen in the articles in part two of this special issue, are crying out for harmonisation both at a procedural but at fundamental conceptual levels. The law of data sharing is pulling in different directions. This paper poses the question, ‘harmonisation, an impossible dream?’ and the answer is a qualified ‘no’. The paper reflects on what can be seen in the papers in part two of the special issue. It then identifies three major areas of conceptual uncertainty in the new EU General Data Protection Regulation (not because it has superiority over other jurisdictions, but because it is a recent revision of data protection law that leaves universal conceptual questions unclear). Thereafter, the potential for Artificial Intelligence to meet some of the shortcomings is discussed. The paper ends with a consideration of the conditions under which data sharing harmonisation might be achieved: an understanding of a human rights approach and citizen sensitivities in considering the ‘public interest’; social liberalism as a basis of solidarity; and the profession of ‘researcher’.
- Open Access
- 1 January 2016
- Published by Cambridge University Press (CUP) in Journal of Law, Medicine & Ethics
- Vol. 44 (1) , 128-142
EU Laws on Privacy in Genomic Databases and Biobanking
Both the European Union and the Council of Europe have a bearing on privacy in genomic databases and biobanking. In terms of legislation, the processing of personal data as it relates to the right to privacy is currently largely regulated in Europe by Directive 95/46/EC, which requires that processing be “fair and lawful” and follow a set of principles, meaning that the data be processed only for stated purposes, be sufficient for the purposes of the processing, be kept only for so long as is necessary to achieve those purposes, and be kept securely and only in an identifiable state for such time as is necessary for the processing. The European privacy regime does not require the de-identification (anonymization) of personal data used in genomic databases or biobanks, and alongside this practice informed consent as well as governance and oversight mechanisms provide for the protection of genomic data.
- 1 January 2016
- Published by Cambridge University Press (CUP) in Journal of Law, Medicine & Ethics
- Vol. 44 (1) , 128-142
Open AccessEU Laws on Privacy in Genomic Databases and Biobanking
Both the European Union and the Council of Europe have a bearing on privacy in genomic databases and biobanking. In terms of legislation, the processing of personal data as it relates to the right to privacy is currently largely regulated in Europe by Directive 95/46/EC, which requires that processing be “fair and lawful” and follow a set of principles, meaning that the data be processed only for stated purposes, be sufficient for the purposes of the processing, be kept only for so long as is necessary to achieve those purposes, and be kept securely and only in an identifiable state for such time as is necessary for the processing. The European privacy regime does not require the de-identification (anonymization) of personal data used in genomic databases or biobanks, and alongside this practice informed consent as well as governance and oversight mechanisms provide for the protection of genomic data.
- Open Access
- 11 August 2015
- Published by Springer Nature in Life Sciences, Society and Policy
- Vol. 11 (1) , 8
Reflections on different governance styles in regulating science: a contribution to ‘Responsible Research and Innovation’
In European science and technology policy, various styles have been developed and institutionalised to govern the ethical challenges of science and technology innovations. In this paper, we give an account of the most dominant styles of the past 30 years, particularly in Europe, seeking to show their specific merits and problems. We focus on three styles of governance: a technocratic style, an applied ethics style, and a public participation style. We discuss their merits and deficits, and use this analysis to assess the potential of the recently established governance approach of ‘Responsible Research and Innovation’ (RRI). Based on this analysis, we reflect on the current shaping of RRI in terms of ‘doing governance’.
- 11 August 2015
- Published by Springer Nature in Life Sciences, Society and Policy
- Vol. 11 (1) , 8
Open AccessReflections on different governance styles in regulating science: a contribution to ‘Responsible Research and Innovation’
In European science and technology policy, various styles have been developed and institutionalised to govern the ethical challenges of science and technology innovations. In this paper, we give an account of the most dominant styles of the past 30 years, particularly in Europe, seeking to show their specific merits and problems. We focus on three styles of governance: a technocratic style, an applied ethics style, and a public participation style. We discuss their merits and deficits, and use this analysis to assess the potential of the recently established governance approach of ‘Responsible Research and Innovation’ (RRI). Based on this analysis, we reflect on the current shaping of RRI in terms of ‘doing governance’.